184 related articles for article (PubMed ID: 18635818)
1. Effects of six APOA5 variants, identified in patients with severe hypertriglyceridemia, on in vitro lipoprotein lipase activity and receptor binding.
Dorfmeister B; Zeng WW; Dichlberger A; Nilsson SK; Schaap FG; Hubacek JA; Merkel M; Cooper JA; Lookene A; Putt W; Whittall R; Lee PJ; Lins L; Delsaux N; Nierman M; Kuivenhoven JA; Kastelein JJ; Vrablik M; Olivecrona G; Schneider WJ; Heeren J; Humphries SE; Talmud PJ
Arterioscler Thromb Vasc Biol; 2008 Oct; 28(10):1866-71. PubMed ID: 18635818
[TBL] [Abstract][Full Text] [Related]
2. ApoAV reduces plasma triglycerides by inhibiting very low density lipoprotein-triglyceride (VLDL-TG) production and stimulating lipoprotein lipase-mediated VLDL-TG hydrolysis.
Schaap FG; Rensen PC; Voshol PJ; Vrins C; van der Vliet HN; Chamuleau RA; Havekes LM; Groen AK; van Dijk KW
J Biol Chem; 2004 Jul; 279(27):27941-7. PubMed ID: 15090553
[TBL] [Abstract][Full Text] [Related]
3. Apolipoprotein AV accelerates plasma hydrolysis of triglyceride-rich lipoproteins by interaction with proteoglycan-bound lipoprotein lipase.
Merkel M; Loeffler B; Kluger M; Fabig N; Geppert G; Pennacchio LA; Laatsch A; Heeren J
J Biol Chem; 2005 Jun; 280(22):21553-60. PubMed ID: 15774484
[TBL] [Abstract][Full Text] [Related]
4. Incidental finding of severe hypertriglyceridemia in children. Role of multiple rare variants in genes affecting plasma triglyceride.
Buonuomo PS; Rabacchi C; Macchiaiolo M; Trenti C; Fasano T; Tarugi P; Bartuli A; Bertolini S; Calandra S
J Clin Lipidol; 2017; 11(6):1329-1337.e3. PubMed ID: 28951076
[TBL] [Abstract][Full Text] [Related]
5. Functional importance of apolipoprotein A5 185G in the activation of lipoprotein lipase.
Huang YJ; Lin YL; Chiang CI; Yen CT; Lin SW; Kao JT
Clin Chim Acta; 2012 Jan; 413(1-2):246-50. PubMed ID: 22008704
[TBL] [Abstract][Full Text] [Related]
6. Genetic Variants Associated with Gestational Hypertriglyceridemia and Pancreatitis.
Xie SL; Chen TZ; Huang XL; Chen C; Jin R; Huang ZM; Zhou MT
PLoS One; 2015; 10(6):e0129488. PubMed ID: 26079787
[TBL] [Abstract][Full Text] [Related]
7. APOA5 and triglyceride metabolism, lesson from human APOA5 deficiency.
Calandra S; Priore Oliva C; Tarugi P; Bertolini S
Curr Opin Lipidol; 2006 Apr; 17(2):122-7. PubMed ID: 16531747
[TBL] [Abstract][Full Text] [Related]
8. Rare and common variants in LPL and APOA5 in Thai subjects with severe hypertriglyceridemia: A resequencing approach.
Khovidhunkit W; Charoen S; Kiateprungvej A; Chartyingcharoen P; Muanpetch S; Plengpanich W
J Clin Lipidol; 2016; 10(3):505-511.e1. PubMed ID: 27206937
[TBL] [Abstract][Full Text] [Related]
9. Mutations in LPL, APOC2, APOA5, GPIHBP1 and LMF1 in patients with severe hypertriglyceridaemia.
Surendran RP; Visser ME; Heemelaar S; Wang J; Peter J; Defesche JC; Kuivenhoven JA; Hosseini M; Péterfy M; Kastelein JJ; Johansen CT; Hegele RA; Stroes ES; Dallinga-Thie GM
J Intern Med; 2012 Aug; 272(2):185-96. PubMed ID: 22239554
[TBL] [Abstract][Full Text] [Related]
10. Efficient lowering of triglyceride levels in mice by human apoAV protein variants associated with hypertriglyceridemia.
Vaessen SF; Sierts JA; Kuivenhoven JA; Schaap FG
Biochem Biophys Res Commun; 2009 Feb; 379(2):542-6. PubMed ID: 19121291
[TBL] [Abstract][Full Text] [Related]
11. Modulation of phenotypic expression of APOA5 Q97X and L242P mutations.
Charrière S; Cugnet C; Guitard M; Bernard S; Groisne L; Charcosset M; Pruneta-Deloche V; Merlin M; Billon S; Delay M; Sassolas A; Moulin P; Marçais C
Atherosclerosis; 2009 Nov; 207(1):150-6. PubMed ID: 19447388
[TBL] [Abstract][Full Text] [Related]
12. Identification and functional characterization of a novel heterozygous missense variant in the LPL associated with recurrent hypertriglyceridemia-induced acute pancreatitis in pregnancy.
Shi XL; Yang Q; Pu N; Li XY; Chen WW; Zhou J; Li G; Tong ZH; Férec C; Cooper DN; Chen JM; Li WQ
Mol Genet Genomic Med; 2020 Mar; 8(3):e1048. PubMed ID: 31962008
[TBL] [Abstract][Full Text] [Related]
13. Additive effects of LPL, APOA5 and APOE variant combinations on triglyceride levels and hypertriglyceridemia: results of the ICARIA genetic sub-study.
Ariza MJ; Sánchez-Chaparro MA; Barón FJ; Hornos AM; Calvo-Bonacho E; Rioja J; Valdivielso P; Gelpi JA; González-Santos P
BMC Med Genet; 2010 Apr; 11():66. PubMed ID: 20429872
[TBL] [Abstract][Full Text] [Related]
14. Apoa5 Q139X truncation predisposes to late-onset hyperchylomicronemia due to lipoprotein lipase impairment.
Marçais C; Verges B; Charrière S; Pruneta V; Merlin M; Billon S; Perrot L; Drai J; Sassolas A; Pennacchio LA; Fruchart-Najib J; Fruchart JC; Durlach V; Moulin P
J Clin Invest; 2005 Oct; 115(10):2862-9. PubMed ID: 16200213
[TBL] [Abstract][Full Text] [Related]
15. Lipoprotein lipase activity determined in vivo is lower in carriers of apolipoprotein A-V gene variants 19W and -1131C.
Kovář J; Adámková V
Physiol Res; 2008; 57(4):555-561. PubMed ID: 17705673
[TBL] [Abstract][Full Text] [Related]
16. Inherited apolipoprotein A-V deficiency in severe hypertriglyceridemia.
Priore Oliva C; Pisciotta L; Li Volti G; Sambataro MP; Cantafora A; Bellocchio A; Catapano A; Tarugi P; Bertolini S; Calandra S
Arterioscler Thromb Vasc Biol; 2005 Feb; 25(2):411-7. PubMed ID: 15591215
[TBL] [Abstract][Full Text] [Related]
17. New rare genetic variants of LMF1 gene identified in severe hypertriglyceridemia.
Serveaux Dancer M; Di Filippo M; Marmontel O; Valéro R; Piombo Rivarola MDC; Peretti N; Caussy C; Krempf M; Vergès B; Mahl M; Marçais C; Moulin P; Charrière S
J Clin Lipidol; 2018; 12(5):1244-1252. PubMed ID: 30037590
[TBL] [Abstract][Full Text] [Related]
18. Intravenous injection of apolipoprotein A-V reconstituted high-density lipoprotein decreases hypertriglyceridemia in apoav-/- mice and requires glycosylphosphatidylinositol-anchored high-density lipoprotein-binding protein 1.
Shu X; Nelbach L; Weinstein MM; Burgess BL; Beckstead JA; Young SG; Ryan RO; Forte TM
Arterioscler Thromb Vasc Biol; 2010 Dec; 30(12):2504-9. PubMed ID: 20966404
[TBL] [Abstract][Full Text] [Related]
19. Post-heparin LPL activity measurement using VLDL as a substrate: a new robust method for routine assessment of plasma triglyceride lipolysis defects.
Di Filippo M; Marçais C; Charrière S; Marmontel O; Broyer M; Delay M; Merlin M; Nollace A; Valéro R; Lagarde M; Pruneta-Deloche V; Moulin P; Sassolas A
PLoS One; 2014; 9(6):e99721. PubMed ID: 24886863
[TBL] [Abstract][Full Text] [Related]
20. Molecular analysis of chylomicronemia in a clinical laboratory setting: diagnosis of 13 cases of lipoprotein lipase deficiency.
Martín-Campos JM; Julve J; Roig R; Martínez S; Errico TL; Martínez-Couselo S; Escolà-Gil JC; Méndez-González J; Blanco-Vaca F
Clin Chim Acta; 2014 Feb; 429():61-8. PubMed ID: 24291057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
